We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Sustained Metabolic Benefits of a Remote Ketogenic Nutrition Program in Veterans with Type 2 Diabetes: A 3-Year Observational Study

MedXY Editorial Team•Oct 2, 2025•Cardiology
Glycemic Controlketogenic diettelemedicinetype 2 diabetesveterans

Introduction

Type 2 diabetes (T2D) presents a significant health burden, particularly among United States veterans who face a disproportionately high prevalence and complexity of comorbid conditions. Veteran populations often contend with compounded challenges such as psychosocial stressors, multimorbidity, and barriers to healthcare access, which can hinder effective diabetes management. Traditional treatment regimens relying heavily on medication intensification frequently encounter issues related to adherence and patient preferences. Hence, innovative, accessible interventions that provide continuous support and empower veterans to manage T2D effectively are critically needed.

Remote telemedicine interventions offer promise for overcoming geographic and logistical barriers in this population. However, many telemedicine programs lack sustained engagement and comprehensive support, limiting long-term clinical impact. A ketogenic nutrition program delivered via continuous remote care—integrating individualized coaching, real-time biomarker monitoring, and medication management—may offer an effective, scalable approach to improve metabolic outcomes in veterans with T2D.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Quantitative Insights into Tirzepatide and Semaglutide Using Longitudinal Systems ModelingThis study uses longitudinal modeling to compare tirzepatide and semaglutide’s effects on fasting glucose in type 2 diabetes, revealing tirzepatide’s superior control largely due to greater insulin-independent hepatic glucose production supSep 23, 2026Empagliflozin Demonstrates Uniform Cardiovascular Benefits Across Diverse Patient Subgroups in Type 2 Diabetes: Insights from the EMPRISE Real-World StudyEmpagliflozin consistently reduces major cardiovascular events, heart failure hospitalizations, and mortality across diverse sociodemographic and cardiovascular risk groups in older adults with type 2 diabetes, with especially pronounced abSep 23, 2026Centralized Multidisciplinary Retinoblastoma Care: Closing Outcome Gaps in Resource-Limited Settings with Telemedicine and Advanced Globe SalvageCentralized multidisciplinary retinoblastoma care incorporating telemedicine and international partnership at KHCC improved survival and globe salvage rates to levels comparable with high-income countries, demonstrating a scalable model forSep 23, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Longitudinal Glycemic Trajectories in Adults with Type 1 Diabetes: Insights from a Three-Year Multicenter CGM StudyThis study investigates three-year continuous glucose monitoring trajectories across clinical subgroups of adults with type 1 diabetes to identify factors influencing glycemic control and variability, highlighting the need for individualizeSep 21, 2026
GLP-1 Receptor Agonists and the Prevention of Obstructive Sleep Apnea in Type 2 Diabetes: Insights from a Large UK Cohort StudyA comprehensive UK cohort study shows that GLP-1 receptor agonists do not reduce the incidence of obstructive sleep apnea compared to DPP-4 inhibitors in obese patients with type 2 diabetes.Sep 19, 2026
Fenofibrate Use and Reduced Risk of Sight-Threatening Diabetic Retinopathy in Type 2 Diabetes: Insights from UK Real-World DataFenofibrate use in type 2 diabetes patients is associated with a significant reduction in the risk of sight-threatening diabetic retinopathy compared to statins, based on UK primary care data over 12 years.Sep 18, 2026